Proteins of the WNT signaling pathway and uses thereof in the diagnostic and treatment of hypopigmentation disorders
US10983134B2 · kind B2 · utility
1Cited by
1References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 16, 2015 |
| Grant date | Apr 20, 2021 |
| Priority date | — |
| Expiry date | Mar 14, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the identification of proteins of the WNT signaling pathway as therapeutic targets of pigmentation disorder and as biomarkers of pigmentation status. The invention in particular relates to products and methods for treating a hypopigmentation disorder. The invention also relates to products and methods for detecting, diagnosing, staging or monitoring the course of hypopigmentation disorder and is particularly suited for human subjects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.